| Miss Heather Rynecki, OTR/L | |
|
201 Franklin Farm Ln, Chambersburg, PA 17202-3060 | |
| (717) 264-2715 | |
| Not Available |
| Full Name | Miss Heather Rynecki |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 201 Franklin Farm Ln, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063814846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OC012973 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Heather Rynecki, OTR/L 201 Franklin Farm Ln, Chambersburg, PA 17202-3060 Ph: () - | Miss Heather Rynecki, OTR/L 201 Franklin Farm Ln, Chambersburg, PA 17202-3060 Ph: (717) 264-2715 |
News Archive
Three new studies examining the predictors, effects and durability of testosterone therapy on men will be presented to reporters at the 109th Annual Scientific Meeting of the American Urological Association (AUA) during a special press conference in the Orange County Convention Center, Orlando, FL on Sunday, May 18 at 2:00 p.m. ET.
Adamis Pharmaceuticals Corporation announced today that the FDA has accepted an Investigational New Drug (IND) application for APC-100 to treat prostate cancer (PCa).
As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.
ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.
Scientists have identified a new protein (C5orf30) which regulates the severity of tissue damage caused by rheumatoid arthritis (RA), an autoimmune disease that causes inflammation, pain, stiffness and damage to the joints of the feet, hips, knees, and hands.
› Verified 5 days ago
Mrs. Kimberly Dawn Chaney, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg Hospital-physical Medicine Department, Chambersburg, PA 17201 Phone: 717-267-7901 Fax: 717-267-7463 | |
Elizabeth Maria Willson, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1035 Leidig Dr, Chambersburg, PA 17201 Phone: 717-264-0956 | |
Mrs. Melissa Sue Cordell, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 55 S 2nd St, Chambersburg, PA 17201 Phone: 717-264-6815 Fax: 717-264-5757 | |
Angelique Catherine Miller, MS,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-262-4650 Fax: 717-262-4658 | |
Cynthia Stuart, M.S., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2085 Wayne Rd, Chambersburg, PA 17202 Phone: 717-261-4137 | |
Kaylee Monninger, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 455 Lincoln Way E, Chambersburg, PA 17201 Phone: 717-446-0439 Fax: 717-312-8998 |